|
FDA approves Allergan's drug (Latisse) for longer eyelashes - Los Angeles, Northridge
Latisse in Los Angeles, San Fernando Valley is available at NewSkin Laser Center.
Allergan Inc, the maker of Botox, said on Friday that the U.S. Food and Drug Administration has approved its eyelash-thickening drug Latisse. Latisse is designed to treat a condition known as hypotrichosis of the eyelashes, which means a person does not have enough eyelashes. The active ingredient in Latisse is bimatroprost, the same ingredient that is in Allergan's glaucoma treatment Lumigan.
NOTE: YOU MUST HAVE A PRESCRIPTION IN ORDER FOR US TO SHIP YOUR LATISSE. EITHER YOU OR YOUR DOCTOR CAN FAX THE PRESCRIPTION TO 818-993-6900
Latisse - Special at NewSkin Laser Center $99 Call Now 818-280-0700
Latisse Special $99 Limited Time!
Patients taking Lumigan found a side effect of the drug to be eyelash growth, prompting Allergan to study it for the new use. Latisse is a once-daily prescription treatment that is applied to the base of the upper eyelash with a sterile, single-use-per-eye disposable applicator. Once treatment is stopped, eyelashes will gradually return to where they were prior to treatment.
Allergan said it estimates global peak sales of Latisse solution could top $500 million a year. Gary Nachman, an analyst at Leerink Swann, said that while approval was expected, "in this cautious environment, every approval through the FDA should be viewed positively." Latisse is the first prescription product for lengthening eyelashes, making sales forecasting a little difficult. Larry Biegelsen, an analyst at Wachovia, said he agrees with the company's forecast of more than $500 million. However, "we think the initial uptake will be muted due to the economic situation."
Biegelsen forecasts sales of $30 million in 2009, growing to $310 million in 2012. Leerink Swann's Nachman said he expects the drug to generate sales of $20 million in 2009, growing to $80 million in 2012. "We believe the opportunity for Latisse could be much larger, but we still need to do more work on this largely unpioneered market," he said. Latisse is a structural prostaglandin analog, a lipid compound derived from fatty acids designed to bind to prostaglandin receptors. These receptors are present in hair and are thought to be involved in the development and regrowth of the hair follicle.
Side effects of Latisse can include eye redness, itchy eyes and a darkening of the eyelid skin. Though not reported in clinical studies, Allergan said Latisse may also cause the colored part of the eye to become browner, a condition that might be permanent. Allergan said it expects to launch the product in the first quarter of 2009.
This product will be far superior than Revitalash and MD Lash Factor. Please note the side effects listed below, which are similar to Revitalash and MD Lash Factor.
Important LATISSE™ Safety Information
LATISSE™ solution is intended for use on the skin of the upper eyelid margins at the base of the eyelashes. DO NOT APPLY to the lower eyelid. If you are using LUMIGAN® or other products in the same class for elevated intraocular pressure (IOP), or if you have a history of abnormal IOP, you should only use LATISSE™ under the close supervision of your doctor.
LATISSE™ use may cause darkening of the eyelid skin which may be reversible. Although not reported in clinical studies, LATISSE™ use may also cause increased brown pigmentation of the colored part of the eye which is likely to be permanent.
It is possible for hair growth to occur in other areas of your skin that LATISSE™ frequently touches. Any excess solution outside the upper eyelid margin should be blotted with a tissue or other absorbent material to reduce the chance of this from happening. It is also possible for a difference in eyelash length, thickness, fullness, pigmentation, number of eyelash hairs, and/or direction of eyelash growth to occur between eyes. These differences, should they occur, will usually go away if you stop using LATISSE™.
The most common side effects after using LATISSE™ solution are an itching sensation in the eyes and/or eye redness. This was reported in approximately 4% of patients. LATISSE™ solution may cause other less common side effects which typically occur on the skin close to where LATISSE™ is applied, or in the eyes. These include skin darkening, eye irritation, dryness of the eyes, and redness of the eyelids.
If you develop a new ocular condition (e.g., trauma or infection), experience a sudden decrease in visual acuity, have ocular surgery, or develop any ocular reactions, particularly conjunctivitis and eyelid reactions, you should immediately seek your doctor's advice concerning the continued use of LATISSE™ solution.
Full prescribing information is available at http://www.latisse.com.
Call now for our special offer on Latisse $99 818-280-0700
NewSkin Laser Center
8540 Reseda Blvd #103
Northridge, CA 91324
818-280-0700
Serving: Los Angeles, San Fernando Valley, Northridge, Porter Ranch, Encino, Tarzana, West Hills, Woodland Hills, Calabasas, Sherman Oaks, Studio City
|
